Ribuot C, Rochette L
Laboratoire de Pharmacodynamie et de Physiologie Pharmaceutique, Faculté de Pharmacie-Université de Dijon, France.
Cardiovasc Drugs Ther. 1987;1(1):51-5. doi: 10.1007/BF02125833.
The angiotensin-converting enzyme inhibitors, captopril, enalapril and perindopril, exert antiarrhythmic effects on early post-infarction arrhythmias in anaesthetized rats. These studies support the hypothesis that converting enzyme inhibitors could have a "cardioprotective" effect, but the doses used are probably "high" in relation to those therapeutically applicable to man.
血管紧张素转换酶抑制剂卡托普利、依那普利和培哚普利,对麻醉大鼠心肌梗死后早期心律失常具有抗心律失常作用。这些研究支持了转换酶抑制剂可能具有“心脏保护”作用的假说,但所用剂量相对于适用于人类治疗的剂量而言可能“过高”。